Advanced Search

 

Study ID Status Title Patient Level Data
HZA109912 Completed A 12-week, randomised, double-blind, placebo-controlled, three-period, cross-over pilot study comparing the effect of salmeterol/fluticasone propionate, fluticasone propionate and placebo on perpheral blood eosinophils and serum IL-5 in response to allergen challenge in asthma subjects when allergen challenge is administered at 1 hour or 11-12 hours post-dose of the dosing interval Study Listed on ClinicalStudyDataRequest.com
HZC111348 Completed Study HZC111348, a repeat-dose study of GW685698/GW642444 Inhalation Powder versus Placebo in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
IBN104125 Completed A multi centre, randomised, open label, cross-over study to evaluate the percentage of false negative osteoporosis diagnosis’s using the standard case-finding procedure as described by the Dutch Institute for Healthcare (CBO) and to determine the preference of adult osteoporosis patients between once monthly dosing of ibandronate (150 mg) and once weekly dosing of alendronate (70 mg)
IDB-200-001 Completed A Randomized, Double-Blind Trial Evaluating the Safety and Immunogenicity of an Influenza Vaccine with reduced Preservative (FluLaval™ TR) and a Standard Influenza Vaccine (Fluarix®) in subjects between 18-60 and Over 60 Years of Age. Study Listed on ClinicalStudyDataRequest.com
IDB-707-105 Completed Active-control study to evaluate the safety, tolerance and immunogenicity of Fluviral™ S/F influenza vaccine in healthy adults aged 18-64 years of age
IDB-707-106 Completed A Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy of Fluviral™ Influenza Vaccine in Healthy Adults 18 to 49 Years of Age
IDB-707-107 Completed Clinical study to evaluate safety, tolerance and immunogenicity of Fluviral® trivalent split virion influenza vaccine (season 2005-2006) in adults aged between 18-60 and over 60
IDB-707-108 Completed Non-Inferiority Comparison of Fluviral™ Influenza Virus Vaccine to a US Licensed Inactivated Split-Virion Vaccine in Adults
IDB-707-109 Completed A Randomized, Double-blind Trial Comparing the Safety and Immunogenicity of Two Lots of Fluviral® Influenza Vaccine in Healthy Adults 18 to 49 Years of Age
IDB-707-110 Completed Clinical Study to Evaluate Safety, Tolerance and Immunogenicity of Fluviral® Trivalent Split Virion Influenza Vaccine (2006 – 2007 Season) in Adults Aged Between 18-60 and over 60
ILI105618 Completed A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18 (SB-485232) Administered by Intravenous Infusion in Combinationwith Rituximab in Adult Patients with B Cell Non-Hodgkin'sLymphoma" Study Listed on ClinicalStudyDataRequest.com
ILI108621 Completed A phase I, dose escalation study to assess the safety & biological activity of Interleukin 18 (SB-485232) administered by IV infusion in combination with pegylated liposomal doxorubicin (Doxil) in advanced stage epithelial ovarian cancer Study Listed on ClinicalStudyDataRequest.com
IMU40001 Completed A randomised, single-dose, three-way cross-over study evaluating the bioequivalence of 50 mg oral doses of the azathioprine formulation manufactured in Germany compared to the azathioprine formulations manufactured in France and UK in healthy volunteers.
IND/SEREACC/PMS Completed Post Marketing Surveillance (PMS) of salmeterol and fluticasone in fixed dose combination (Seretide® Accuhaler) in the Treatment of Bronchial Asthma.
India Flixonase PMS (no study number) Completed Title Post Marketing Surveillance of Flixonase (Fluticasone Propionate Aqueous Nasal Spray (FPANS)) to Evaluate the Safety of Fluticasone 200 micrograms (mcg) Nasal Spray in Indian Patients with Allergic Rhinitis
ING111207 Completed A Double-Blind, Randomized, Placebo-Controlled, Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1349572 in Healthy Subjects
ING111322 Completed GSK1349572 Repeat Dose Escalation Study
INO102141 Completed A two-centre, randomised, double-blind, double-dummy, placebo-controlled, 3-period cross-over study to evaluate the effect of treatment with repeat doses of GW274150 on the allergen-induced late asthmatic response in subjects with mild asthma.
INT 2767 Completed Interaction Study of 975mg Aspirin Given at Steady State of 10mg/sc SR90107A/Org31540 in Healthy Male Subjects
INT 3012 Completed Influence of Forced Diuresis on the Pharmacokinetics of Org31540/SR90107 After a Single Dose of 10 mg s.c. of Org31540/SR90107A in Healthy Male Subjects
INT3933 Completed Assessment of pharmacokinetic and pharmacodynamic drug interactions between ORG31540/SR90107A and digoxin in healthy male subjects
INT-CAR-13 Completed Effect of carvedilol as compared to an ACE-inhibitor (enalapril) on hypertension and “quality of life” related well-being.
IP2107882 Completed A single-centre, randomized, double-blind , placebo controlled, dose escalating cross-over study to evaluate the safety, tolerability and pharmacokinetics of single inhaled doses of GSK610677 and placebo in healthy male subjects
IPA101985 Completed A two-centre, randomised, double-blind, placebo-controlled, 2-period cross-over study to evaluate the effect of treatment with repeat doses of inhaled GSK256066 on the allergen-induced late asthmatic response in subjects with mild asthma
IPC101939 Completed A randomised, double-blind, placebo-controlled study to investigate the safety and tolerability of inhaled GSK256066 in mild to moderate COPD patients

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.